glp 1 nafld Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis glp-1 fatty liver Multiple target

Aging 15 , 28242851 (2023)

doi: 10.1001/jama.2022.14236 54 MaggiPBulckeCVPedriniEBugliCSellimiAWynenMet al

However, genetic variants in GLP-1 receptor (GLP1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) genes influence how strongly an individual's gut responds to these medications, explaining why some tolerate them better than others

I commonly see: Decreased appetite Earlier fullness Fewer cravings Mild or modest scale changes Typical weight loss: 38 pounds Some patients feel slow progress early this is normal during dose escalation

Randomized trials and metaanalyses rarely identify headache as a frequent serious problem, but individual reports and postmarketing data show some people experience headaches they attribute to supplementation